THCT (THC Therapeutics) Cyclically Adjusted FCF per Share: $0.00 (As of Jul. 2024)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is THC Therapeutics Cyclically Adjusted FCF per Share?

THC Therapeutics THCT Cyclically Adjusted FCF per Share is $0.00 as of Jul. 2024.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

THC Therapeutics's adjusted free cash flow per share for the three months ended in Jul. 2024 was $0.000. Add all the adjusted free cash flow per share for the past 10 years together and divide the count will get our Cyclically Adjusted FCF per Share, which is $0.00 for the trailing ten years ended in Jul. 2024.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted FCF Growth Rate using Cyclically Adjusted FCF per Share data.

As of today (2026-08-02), THC Therapeutics's current stock price is $0.0006. THC Therapeutics's Cyclically Adjusted FCF per Share for the quarter that ended in Jul. 2024 was $0.00. THC Therapeutics's Cyclically Adjusted Price-to-FCF of today is .


THC Therapeutics  (OTCPK:THCT) Cyclically Adjusted FCF per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted FCF per Share may underestimate the company's free cash flow. Cyclically Adjusted Price-to-FCF can seem to be too high even the actual Price-to-Free-Cash-Flow is low.

For the Cyclically Adjusted Price-to-FCF, the free cash flow per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/FCF calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted Price-to-FCF is also called CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.


Be Aware

Cyclically Adjusted Price-to-FCF works better for cyclical companies. It gives you a better idea on the company's real free cash flow value.


THC Therapeutics Cyclically Adjusted FCF per Share Related Terms


THC Therapeutics Cyclically Adjusted FCF per Share Historical Data

* Premium members only.

The historical data trend for THC Therapeutics's Cyclically Adjusted FCF per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

THC Therapeutics Cyclically Adjusted FCF per Share Chart

THC Therapeutics Annual Data
Trend Jul15 Jul16 Jul17 Jul18 Jul19 Jul20 Jul21 Jul22 Jul23 Jul24
Cyclically Adjusted FCF per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.08 -0.07 -0.07 0.00 0.00

THC Therapeutics Quarterly Data
Oct19 Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24
Cyclically Adjusted FCF per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 -0.04 -0.03 0.00

THCT vs ZTS, UTHR, NBIX: Cyclically Adjusted FCF per Share Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, THC Therapeutics's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


THC Therapeutics Cyclically Adjusted Price-to-FCF vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, THC Therapeutics's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where THC Therapeutics's Cyclically Adjusted Price-to-FCF falls into.



THC Therapeutics Cyclically Adjusted FCF per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

What is Cyclically Adjusted FCF per Share? How do we calculate Cyclically Adjusted FCF per Share?

Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted FCF per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the free cash flow per share from 2001 through 2010.

We adjusted the 2001 free cash flow per share data with the total inflation from 2001 through 2010 to the equivalent free cash flow in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's free cash flow is $1 a share in 2001, then the 2001's equivalent free cash flow in 2010 is $1.4 a share. If Wal-Mart's free cash flow is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 free cash flow in 2010 is $1.35. So on and so forth, you get the equivalent free cash flow per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, THC Therapeutics's adjusted Free Cash Flow per Share data for the three months ended in Jul. 2024 was:

Adj_FreeCashFlowPerShare= Free Cash Flow per Share /CPI of Jul. 2024 (Change)*Current CPI (Jul. 2024)
=-0/314.5400*314.5400
=0.000

Current CPI (Jul. 2024) = 314.5400.

THC Therapeutics Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201410 -0.009 237.433 -0.012
201501 0.000 233.707 0.000
201504 0.000 236.599 0.000
201507 0.000 238.654 0.000
201510 -0.004 237.838 -0.005
201601 -0.006 236.916 -0.008
201604 -0.018 239.261 -0.024
201607 -0.006 240.628 -0.008
201610 -0.013 241.729 -0.017
201701 0.045 242.839 0.058
201704 -0.016 244.524 -0.021
201707 -0.004 244.786 -0.005
201710 -0.003 246.663 -0.004
201801 -0.005 247.867 -0.006
201804 -0.005 250.546 -0.006
201807 -0.003 252.006 -0.004
201810 -0.001 252.885 -0.001
201901 -0.005 251.712 -0.006
201904 -0.003 255.548 -0.004
201907 -0.015 256.571 -0.018
201910 -0.009 257.346 -0.011
202001 -0.008 257.971 -0.010
202004 -0.008 256.389 -0.010
202007 -0.011 259.101 -0.013
202010 -0.003 260.388 -0.004
202101 -0.007 261.582 -0.008
202104 -0.005 267.054 -0.006
202107 -0.001 273.003 -0.001
202110 -0.005 276.589 -0.006
202201 -0.004 281.148 -0.004
202204 -0.003 289.109 -0.003
202207 -0.001 296.276 -0.001
202210 -0.001 298.012 -0.001
202301 -0.002 299.170 -0.002
202304 0.000 303.363 0.000
202307 0.000 305.691 0.000
202310 0.000 307.671 0.000
202401 -0.001 308.417 -0.001
202404 -0.004 313.548 -0.004
202407 0.000 314.540 0.000

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

What does a Cyclically Adjusted FCF per Share of $0.00 mean?
THC Therapeutics (THCT) has a Cyclically Adjusted FCF per Share of $0.00 as of Jul. 2024. Cyclically Adjusted FCF per Share represents the company's inflation-adjusted FCF per share over a 10-year period. View historical data on THC Therapeutics and its competitors.
Is THC Therapeutics' Cyclically Adjusted FCF per Share too high?
THC Therapeutics' current Cyclically Adjusted FCF per Share is $0.00.
How does THC Therapeutics' Cyclically Adjusted FCF per Share compare to ZTS and UTHR?
THC Therapeutics' Cyclically Adjusted FCF per Share of $0.00 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted FCF per Share for a Drug Manufacturers company?
A good Cyclically Adjusted FCF per Share depends on the Drug Manufacturers industry context. However, Cyclically Adjusted FCF per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted FCF per Share mean?
A high Cyclically Adjusted FCF per Share can signal that a stock is expensive relative to its fundamentals. Cyclically Adjusted FCF per Share represents the company's inflation-adjusted FCF per share over a 10-year period. View historical data on THC Therapeutics and its competitors. THC Therapeutics's current Cyclically Adjusted FCF per Share is $0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is THC Therapeutics stock overvalued right now?
THC Therapeutics (THCT) has a current Cyclically Adjusted FCF per Share of $0.00. The current Cyclically Adjusted FCF per Share is $0.00. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted FCF per Share calculated?
Cyclically Adjusted FCF per Share is calculated from a company's financial statements. For THC Therapeutics (THCT), the current Cyclically Adjusted FCF per Share is $0.00 as of Jul. 2024. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

THC Therapeutics Business Description

Address 203 S Church Steet, Jacksboro, TX, USA, 76458
Website https://thct.io
THC Therapeutics Inc is a United States-based company. It is focused on developing a sanitizing herb dryer, the dHydronator, which has been specifically designed for the drying and sanitizing i.e., reducing the bacterial count of freshly harvested cannabis, and other herbs, flowers, and tea leaves. The main function of the dHydronator is to accelerate the drying time of an herb while sanitizing it. The dHydronator can be used to dry a variety of herbs, and it has been specifically tested for use with cannabis.